2015
DOI: 10.4172/2167-1095.1000202
|View full text |Cite
|
Sign up to set email alerts
|

Postoperative Hypertension: Novel Opportunities in the Treatment of a Common Complication

Abstract: Acute Postoperative Hypertension (APH) is one of the most common complications detected after surgery. It is a condition associated to a great number of causes and a pathophysiology still unclear which recognizes a central role in sympathetic activation. For these reasons, an ideal agent for treating APH does not exist, but we have to choose the most appropriate therapeutic strategy based on the individual case. We have reviewed some of the most important available treatments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
0
2

Year Published

2018
2018
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 14 publications
0
3
0
2
Order By: Relevance
“…By this definition, postoperative hypertension is associated with myocardial ischemia, infarction, arrhythmias, congestive heart failure with resulting pulmonary edema, stroke, and bleeding. [10][11][12][13][14] In patients recovering from cardiac surgery, it is common to start antihypertensive treatment when MAP reaches 105 mm Hg. 11,13 We chose MAP values of 110 and 130 mm Hg as thresholds for hypertension and severe hypertension, and again to avoid shortlived artifacts, we required episodes to last at least 30 min.…”
Section: Discussionmentioning
confidence: 99%
“…By this definition, postoperative hypertension is associated with myocardial ischemia, infarction, arrhythmias, congestive heart failure with resulting pulmonary edema, stroke, and bleeding. [10][11][12][13][14] In patients recovering from cardiac surgery, it is common to start antihypertensive treatment when MAP reaches 105 mm Hg. 11,13 We chose MAP values of 110 and 130 mm Hg as thresholds for hypertension and severe hypertension, and again to avoid shortlived artifacts, we required episodes to last at least 30 min.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the widespread and longstanding recognition of acute postoperative hypertension (APH), there is no consensus on a more precise, quantitative definition [32]. Some authors define APH as systolic BP > 190 mmHg with or without diastolic BP ≥ 100 mmHg in at least two consecutive measurements postoperatively [33], while others recommend treatment threshold for APH as BP > 160/90 mmHg or greater than 20% elevation from preoperative baseline BP [32]. APH can begin to manifest in the first 20 minutes postoperatively and lasts on average 3-4 hours [33].…”
Section: Recommendations For Postoperative Hypertension In Patients Recovering In the Post-anesthesia Care Unitmentioning
confidence: 99%
“…Some authors define APH as systolic BP > 190 mmHg with or without diastolic BP ≥ 100 mmHg in at least two consecutive measurements postoperatively [33], while others recommend treatment threshold for APH as BP > 160/90 mmHg or greater than 20% elevation from preoperative baseline BP [32]. APH can begin to manifest in the first 20 minutes postoperatively and lasts on average 3-4 hours [33]. These patients often have a history of chronic hypertension, and the postoperative hypertension is usually transient in nature.…”
Section: Recommendations For Postoperative Hypertension In Patients Recovering In the Post-anesthesia Care Unitmentioning
confidence: 99%
“…β-Адреноблокатор эсмолол удобен для купирования ПАГ у кардиохирургических больных благодаря высокой управляемости его действием. Он обладает быстрым (в течение 60-120 с) и непродолжительным (10-20 мин) эффектом, может использоваться в виде непрерывной инфузии [14,15]. Препарат можно применять при заболеваниях печени или почек.…”
Section: таблица 2 динамика ад и чсс в первые послеоперационные суткиunclassified
“…Он метаболизируется печенью и имеет продолжительность действия до 4 ч, поэтому препарат применяют в виде непрерывной инфузии. Болюсные инъекции 1-2 мг/кг могут приводить к резко-му снижению АД [14,15]. Лабеталол не должен использоваться у пациентов с синусовой брадикардией, бронхиальной астмой и нарушениями ритма сердца [21].…”
Section: таблица 2 динамика ад и чсс в первые послеоперационные суткиunclassified